Research Needed To Improve Survival In Adolescents, Young Adults With Cancer
Novel Compounds Alone Or Combined With Chemo Tested In Blood Cancers
Non-Chemo Agents Added To Regimens For Lymphomas
New Compounds To Treat Gleevec-Resistant CML
Campath Improves PFS In B-Cell CLL In Phase III Trial
NCI-Approved Clinical Trials
Trending Stories
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.” - At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival









